C22 Glucosylceramide (d18:1/22:0) – 1 mg

Brand:
Cayman
CAS:
119242-44-3
Storage:
-20
UN-No:
Non-Hazardous - /

C22 Glucosylceramide is an endogenous glucosylceramide.{41137,41138,41139} Glucosylceramides are major constituents of skin lipid membranes where they play a role in maintaining the water permeability barrier. They are precursors in the synthesis of lactosylceramide (Item No. 16983), as well as oligoglycolipids and gangliosides. Phospholipase A2 (PLA2) type XIIA knockdown increases C22 glucosylceramide expression in rat brain.{41139} It is also increased in the brain, but not the liver or spinal cord, of mice fed a methionine-restricted diet.{41138} In human athletes, plasma levels of C22 glucosylceramide increase during exercise and return to basal levels during recovery.{41137} This product contains C22 glucosylceramide isolated from bovine buttermilk. [Matreya, LLC. Catalog No. 1531]  

 

Available on backorder

SKU: 23210 - 1 mg Category:

Description

An endogenous glucosylceramide; PLA2 type XIIA knockdown increases expression in rat brain; increased in the brain, but not the liver or spinal cord, of mice fed a methionine-restricted diet; plasma levels increase during exercise and return to basal levels during recovery in human athletes; product contains C22 glucosylceramide isolated from bovine buttermilk


Formal name: N-[(1S,2R,3E)-1-[(β-D-glucopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-docosanamide

Synonyms:  C22 Glucosylceramide|GluCer(18:1/22:0)|Glucosylceramide (d18:1/22:0|N-C22:0-Glucocerebroside|N-Docosanoyl-glucopsychosine|N-Docosanoyl-β-glucosylsphingosine

Molecular weight: 784.2

CAS: 119242-44-3

Purity: ≥98%

Formulation: A solid


Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Lipid Biochemistry|Sphingolipids||Research Area|Neuroscience